G.A. Robichaud, R., Ouellette et J.P. Perreault. Functional characterization of the human Pax-5gene in B lymphocytes through the use of enhanced deltaribozymes. En préparation pour "Journal of Biological Chemistry"
G.A. Robichaud, F. Brière et J.P. Perreault. The SOFA-deltaribozyme: A stable and non-toxic approach as a therapeutic agent and molecular research tool. En préparation pour "Journal of Biological Chemistry - Drug Discovery Today"
M. Laflamme and G.A. Robichaud Microarray Technology for the Study of Gene Regulation and Pathway Analysis: Front- and Back-side Applications. Article soumis à OMICS; déc. 2006
Gilles A. Robichaud, Michel Nardini, Mark Laflamme, Mira Cuperlovic-Culf, Rodney J. Ouellette. Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. Journal of Biological Chemistry; 2004, 279(48):49956-49963
Mira Culf, Gilles A. Robichaud, Michel Nardini and Rodney Ouellette. Investigation of interaction between Pax-5isoforms and thioredoxin using de novomodeling methods. In Silico Biology; 2003, 3(38):453-469
Carle Ryckman, Gilles A. Robichaud, Jocelin Roy, Réjean Cantin, Michel J. Tremblay and Philippe A. Tessier. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. Journal of Immunology; 2002, 169(6):3307-3313
Gilles A. Robichaud, Benoit Barbeau, Jean-Francois Fortin, and Michel J. Tremblay. NFAT is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. Journal of Biological Chemistry; 2002; 277(26):23733-23741
Benoit Barbeau*, Gilles A. Robichaud*, Jean-Francois Fortin and Michel J. Tremblay. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. Journal of Immunology; 2001; 167(5):2700-2713
Jean-Francois Fortin, Benoit Barbeau, Gilles A. Robichaud, Marie-Eve Paré, Anne-Marie Lemieux and Michel J. Tremblay. Regulation of NFAT by phosphotyrosyl-specific phosphatase activity: A positive effect on HIV-1 LTR-driven transcription and a possible implication of SHP-1. Blood; 2001, 97(8): 2390-2400
Gilles A. Robichaudand Louise Poulin. The HIV-1 Nefgene inhibits TNF-a-induced apoptosis and promotes cell proliferation through the action of MAPK and related kinases in human glial cells. AIDS Research and Human Retroviruses; 2000, 16(18): 1959-1965
Gilles A. Robichaud*, Nicolas Genois* and Michel J. Tremblay.Mono Mac 1: A New in vitro Model System to Study HIV-1 Infection in human cells of the mononuclear phagocyte series. Journal of Leukocyte Biology; 2000, 68: 854-864
Jean-François Fortin, Benoit Barbeau, Gilles A. Robichaudand Michel J. Tremblay. T cell activation and regulation of HIV-1: Same effectors with distinct outcomes. Canadian Journal of Infectious Diseases; 1999, 10: 25-32
Alain Richard,*Gilles A. Robichaud*, Réjean Lapointe, Sylvain Bourgoin, André Darveau and Louise Poulin. Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumor necrosis factor-alpha in human glial cells. AIDS; 1997, 11:F1-F7